by
Joan Trombetti, Writer | March 20, 2009
Edwards Lifesciences Corporation, the world leader in the science of heart valves, announced that the District Court of Dusseldorf, Germany, determined that it does not infringe on Cook Inc.'s German transcatheter valve patent.
A counter-suit by Edwards claiming invalidity of Cook's German patent is expected to be heard in Munich in 2010. Edwards has a separate lawsuit against Cook in the United Kingdom that challenges the validity of Cook's UK transcatheter valve patent. Cook has counter-sued there, claiming infringement. That case is scheduled to be heard in May.
About Edwards Lifesciences
Ad Statistics
Times Displayed: 6
Times Visited: 2 Fast-moving cardiac structures have a big impact on imaging. Fujifilm’s SCENARIA View premium performance CT brings solutions to address motion in Coronary CTA while delivering unique dose saving and workflow increasing benefits.
Edwards Lifesciences is the global leader in the science of heart valves and hemodynamic monitoring, with more than five decades of experience in partnering with clinicians to develop life-saving innovations. Headquartered in Irvine, Calif., Edwards treats advanced cardiovascular disease with its market-leading heart valve therapies, and critical care and vascular technologies, which are sold in approximately 100 countries. The company's global brands include Carpentier-Edwards, Cosgrove-Edwards, Edwards SAPIEN, FloTrac, Fogarty, PERIMOUNT Magna and Swan-Ganz. Additional company information can be found at http://www.edwards.com.
